Quality key factors
Factor
Value
Sales Growth (5y)
-10.50%
EBIT Growth (5y)
-199.00%
EBIT to Interest (avg)
-41.69
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.93
Sales to Capital Employed (avg)
0.05
Tax Ratio
2.55%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
7.08
EV to EBIT
-23.05
EV to EBITDA
-24.73
EV to Capital Employed
93.34
EV to Sales
207.81
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-404.98%
ROE (Latest)
-27.29%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bearish
Dow Theory
Bearish
Bearish
OBV
Bullish
Bullish
Technical Movement
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for Ambrx Biopharma, Inc.
Cash and Cash Equivalents - Half Yearly
Highest at USD 228.93 MM
in the last six half yearly periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents (USD MM)
Here's what is not working for Ambrx Biopharma, Inc.
Operating Cash Flow - Annually
Lowest at USD -68.68 MM and Fallen
each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)






